Cytoplasmic versus nuclear localization of androgen receptor splice variant 7 as a predictor of benefit from androgen receptor pathway inhibitors in metastatic castration-resistant prostate cancer (PROPHECY trial)

<p>Prostate Cancer and Prostatic Diseases, Published online: 02 April 2026; <a href="https://www.nature.com/articles/s41391-026-01113-8">doi:10.1038/s41391-026-01113-8</a></p>Cytoplasmic versus nuclear localization of androgen receptor splice variant 7 as a predictor of benefit from androgen receptor pathway inhibitors in metastatic castration-resistant prostate cancer (PROPHECY trial)